Accelerating the shift toward person-generated real world evidence

19 September 2019 - Evidence generated from randomised clinical trials and other clinical studies has long been the foundation for ...

Read more →

Humana CEO: competition and innovation lower drug prices better than just putting a cap on them

20 September 2019 - U.S. lawmakers should also include in their proposals rules that would facilitate greater competition and innovation, Humana ...

Read more →

How an 'International Price Index' might help reduce drug prices

19 September 2019 - In gridlocked Washington, both Democrats and Republicans have signalled there's potential for a deal when it ...

Read more →

5 people setting EU drug prices

19 September 2019 - Politic’s guide to the policy makers debating how to calculate the cost of cures. ...

Read more →

FDA continues to take steps to fulfil its commitment to strengthen and modernise the 510(k) medical device program

19 September 2019 - The U.S. FDA today announced that, as a first step toward implementation of the recently established Safety ...

Read more →

McConnell warns Pelosi's drug pricing plan is DOA

19 September 2019 - Senate Republicans are warning Speaker Nancy Pelosi that her much-anticipated drug pricing plan is dead and ...

Read more →

Pelosi’s drug plan would let U.S. negotiate prices of 250 medications

19 September 2019 - Speaker Nancy Pelosi on Thursday released her long-awaited plan to curb soaring prices of prescription drugs, ...

Read more →

Flawed evidence underpins approval of new cancer drugs

18 September 2019 - We must raise the bar to ensure real benefits for patients ...

Read more →

Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis

18 September 2019 - In this study, the investigators examined the characteristics of randomised controlled trials that supported approval of cancer ...

Read more →

Electronic prescribing

19 September 2019 - Electronic Prescribing will provide an option for prescribers (including doctors, dentists, optometrists, midwives and nurse practitioners), and ...

Read more →

FDA issues final guidance to address ‘gaming’ by the use of citizen petitions

18 September 2019 - Today the U.S. FDA issued the final guidance, Citizen Petitions and Petitions for Stay of Action Subject ...

Read more →

FDA continues steps to promote innovation in medical devices that help advance patient safety through the Safer Technologies Program

18 September 2019 - Today, the Food and Drug Administration issued draft guidance titled “Safer Technologies Program for Medical Devices,” ...

Read more →

Price controls for Medicare don't put America first

17 September 2019 - Instead of embracing drug price controls, the U.S. should pressure other nations to abandon them. ...

Read more →

FDA takes first action under new international collaboration with Australia and Canada designed to provide a framework for concurrent review of cancer therapies, approving treatment for patients with endometrial carcinoma

17 September 2019 - The U.S. FDA is announcing Project Orbis, an initiative of the FDA Oncology Center of Excellence.  ...

Read more →

Prescription drug price gouging must stop

16 September 2019 - How big pharma can be prevented from indiscriminately raising the prices of its drugs. ...

Read more →